| Literature DB >> 29956029 |
Ewen A Griffiths1,2, James Hodson3, Ravi S Vohra4, Paul Marriott5,6, Tarek Katbeh7, Samer Zino7, Ahmad H M Nassar8.
Abstract
BACKGROUND: A reliable system for grading operative difficulty of laparoscopic cholecystectomy would standardise description of findings and reporting of outcomes. The aim of this study was to validate a difficulty grading system (Nassar scale), testing its applicability and consistency in two large prospective datasets.Entities:
Keywords: Cholecystectomy; Difficulty grading; Laparoscopic; Operative difficulty; Surgery
Mesh:
Year: 2018 PMID: 29956029 PMCID: PMC6336748 DOI: 10.1007/s00464-018-6281-2
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Fig. 1Laparoscopic photos of each Nassar operative difficulty grade. Intra-operative laparoscopic images of the Nassar operative difficulty grades are shown
Comparison of demographic, pre-operative factors, operative factors and patient outcomes between the cohorts
| Reference dataset | CholeS dataset | ||||
|---|---|---|---|---|---|
| Valid | Statistic | Valid | Valid | ||
| Demographics | |||||
| Age | 4030 | 50.4 ± 15.9 | 8748 | 51.0 ± 16.5 | 0.067 |
| Gender (male) | 4068 | 981 (24.1%) | 8755 | 2281 (26.1%) |
|
| Diagnosis | 4048 | 8749 | < | ||
| CBD stone | 598 (14.8%) | 557 (6.4%) | |||
| Cholecystitis | 674 (16.7%) | 2530 (28.9%) | |||
| Colic | 2502 (61.8%) | 4816 (55.0%) | |||
| Pancreatitis | 274 (6.8%) | 846 (9.7%) | |||
| Admission type | 4027 | 8755 | < | ||
| Delay | 861 (21.4%) | 3247 (37.1%) | |||
| Elective | 1883 (46.8%) | 4117 (47.0%) | |||
| Emergency | 1283 (31.9%) | 1391 (15.9%) | |||
| Pre-operative investigations | |||||
| USS | 4089 | 3769 (92.2%) | 8744 | 8409 (96.2%) | < |
| Thick-walled gallbladder | 4089 | 565 (13.8%) | 8548 | 2800 (32.8%) | < |
| CBD dilation | 4089 | 639 (15.6%) | 8552 | 1351 (15.8%) | 0.814 |
| CT | 4089 | 66 (1.6%) | 8654 | 1257 (14.5%) | < |
| MRCP | 4089 | 173 (4.2%) | 8662 | 2264 (26.1%) | < |
| ERCP | 4089 | 143 (3.5%) | 8650 | 931 (10.8%) | < |
| Peri-operative factors | |||||
| Nassar scale | 4035 | 8680 | < | ||
| 1 | 1359 (33.7%) | 3524 (40.6%) | |||
| 2 | 1260 (31.2%) | 2608 (30.0%) | |||
| 3 | 802 (19.9%) | 1769 (20.4%) | |||
| 4/5 | 614 (15.2%) | 779 (9.0%) | |||
| ASA | 3496 | 8681 | 0.501* | ||
| 1 | 1455 (41.6%) | 3354 (38.6%) | |||
| 2 | 1570 (44.9%) | 4436 (51.1%) | |||
| 3 | 464 (13.3%) | 869 (10.0%) | |||
| 4/5 | 7 (0.2%) | 22 (0.3%) | |||
| Duration of surgery (min) | 4054 | 60 (45–85) | 8550 | 62 (47–90) | < |
| Bile spilt | 4089 | 199 (4.9%) | 8690 | 2343 (27.0%) | < |
| Stones spilt | 4089 | 102 (2.5%) | 8677 | 830 (9.6%) | < |
| Bleeding | 4089 | 16 (0.4%) | 8677 | 739 (8.5%) | < |
| Bowel injury | 4089 | 3 (0.1%) | 8674 | 48 (0.6%) | < |
| CBD injury | 4089 | 2 (0.0%) | 8615 | 23 (0.3%) |
|
| Post-surgical drain | 3928 | 2039 (51.9%) | 8735 | 1609 (18.4%) | < |
| Converted to open | 4015 | 27 (0.7%) | 8755 | 297 (3.4%) | < |
| Cholangiography | 4064 | 3635 (89.4%) | 8751 | 1052 (12.0%) | < |
| CBD explored | 4088 | 874 (21.4%) | 8745 | 256 (2.9%) | < |
| Patient outcomes | |||||
| Total length of stay (days) | 2077 | 3 (1–6) | 8719 | 1 (0–2) | < |
| 30-day readmissions | 4089 | 93 (2.3%) | 8755 | 618 (7.1%) | < |
| 30-day complications | 4089 | 297 (7.3%) | 8755 | 937 (10.7%) | < |
| 30-day reintervention | 4089 | 62 (1.5%) | 8755 | 762 (8.7%) | < |
| 30-day mortality | 4089 | 4 (0.1%) | 8755 | 10 (0.1%) | 1.000 |
Data reported as N (%), with p values from Fisher’s exact tests, or as mean ± SD, with p values from t tests, unless stated otherwise. Valid N = the number of patients for whom data were available.
*p value from Kendall’s tau, as the factor was ordinal
Bold p values are significant at p < 0.05
Associations between Nassar operative difficulty scale and operative factors and patient outcomes
| Nassar operative difficulty scale | |||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4/5 | ||
| Peri-operative factors | |||||
| Duration of surgery (min) | |||||
| CholeS | 55 (40–70) | 60 (50–83) | 80 (60–105) | 110 (80–145) | < |
| Reference | 45 (35–60) | 60 (45–75) | 73 (55–95) | 110 (85–150) | < |
| Bile spilt | |||||
| CholeS | 528 (15.1%) | 665 (25.7%) | 717 (40.7%) | 422 (54.5%) | < |
| Reference | 48 (3.5%) | 54 (4.3%) | 55 (6.9%) | 42 (6.8%) | < |
| Stones spilt | |||||
| CholeS | 85 (2.4%) | 171 (6.6%) | 316 (18.0%) | 254 (32.9%) | < |
| Reference | 9 (0.7%) | 27 (2.1%) | 31 (3.9%) | 35 (5.7%) | < |
| Bleeding | |||||
| CholeS | 114 (3.3%) | 217 (8.4%) | 221 (12.6%) | 183 (23.7%) | < |
| Reference | 5 (0.4%) | 3 (0.2%) | 3 (0.4%) | 5 (0.8%) | 0.352 |
| Bowel injury | |||||
| CholeS | 6 (0.2%) | 13 (0.5%) | 9 (0.5%) | 20 (2.6%) | < |
| Reference | 0 (0.0%) | 0 (0.0%) | 1 (0.1%) | 2 (0.3%) | 0.091 |
| CBD injury | |||||
| CholeS | 1 (0.0%) | 5 (0.2%) | 3 (0.2%) | 13 (1.7%) | < |
| Reference | 0 (0.0%) | 1 (0.1%) | 0 (0.0%) | 1 (0.2%) | 0.325 |
| Post-surgical drain | |||||
| CholeS | 205 (5.8%) | 280 (10.7%) | 574 (32.5%) | 539 (69.3%) | < |
| Reference | 328 (25.1%) | 553 (45.5%) | 566 (73.6%) | 568 (95.9%) | < |
| Converted to open | |||||
| CholeS | 7 (0.2%) | 12 (0.5%) | 65 (3.7%) | 212 (27.2%) | < |
| Reference | 2 (0.1%) | 1 (0.1%) | 4 (0.5%) | 20 (3.4%) | < |
| Patient outcomes | |||||
| Total length of stay (days) | |||||
| CholeS | 0 (0–1) | 1 (0–1) | 1 (0–3) | 4 (1–8) | < |
| Reference | 2 (1–4) | 3 (1–5) | 4 (2–7) | 6 (4–9) | < |
| 30-day readmissions | |||||
| CholeS | 226 (6.4%) | 180 (6.9%) | 134 (7.6%) | 65 (8.3%) |
|
| Reference | 19 (1.4%) | 31 (2.5%) | 20 (2.5%) | 22 (3.6%) |
|
| 30-day complications | |||||
| CholeS | 267 (7.6%) | 258 (9.9%) | 204 (11.5%) | 190 (24.4%) | < |
| Reference | 65 (4.8%) | 74 (5.9%) | 80 (10.0%) | 78 (12.7%) | < |
| 30-day reintervention | |||||
| CholeS | 230 (6.5%) | 202 (7.7%) | 160 (9.0%) | 157 (20.2%) | < |
| Reference | 9 (0.7%) | 14 (1.1%) | 16 (2.0%) | 22 (3.6%) | < |
| 30-day mortality | |||||
| CholeS | 1 (0.0%) | 0 (0.0%) | 4 (0.2%) | 5 (0.6%) |
|
| Reference | 0 (0.0%) | 0 (0.0%) | 1 (0.1%) | 3 (0.5%) |
|
Data reported as N (%), with p values from Kendall’s Tau, or as median (IQR), with p values from Jonckheere–Terpstra tests, as applicable
Bold p values are significant at p < 0.05
Fig. 2Rates of key factors and outcomes by Nassar operative difficulty scale in the two cohorts
ROC curve analysis of the associations between Nassar operative difficultly scale and operative factors and patient outcomes
| AUROC (SE) | ||
|---|---|---|
| CholeS | Reference | |
| Peri-operative factors | ||
| Duration of surgery > 90 min | 0.743 (0.007) | 0.797 (0.009) |
| Bile spilt | 0.673 (0.007) | 0.580 (0.021) |
| Stones spilt | 0.764 (0.009) | 0.695 (0.024) |
| Bleeding | 0.693 (0.010) | 0.574 (0.080) |
| Bowel injury | 0.727 (0.038) | 0.866 (0.056) |
| CBD injury | 0.811 (0.046) | 0.709 (0.160) |
| Post-surgical drain | 0.789 (0.007) | 0.777 (0.007) |
| Converted to open | 0.903 (0.009) | 0.830 (0.042) |
| Patient outcomes | ||
| Total length of stay > 5 days | 0.698 (0.010) | 0.692 (0.014) |
| 30-day readmissions | 0.525 (0.012) | 0.586 (0.029) |
| 30-day complications | 0.603 (0.010) | 0.612 (0.017) |
| 30-day reintervention | 0.593 (0.011) | 0.670 (0.035) |
| 30-day mortality | 0.822 (0.071) | 0.880 (0.045) |
Data reported as area under ROC curves (AUROC) and standard errors (SE)
Associations between pre-operative factors and selected outcomes in the CholeS cohort
|
| Duration of surgery | Converted to open | 30-day complications | 30-day reintervention | |
|---|---|---|---|---|---|
| Age (years) | |||||
| < 40 | 2346 | 60 (45–80) | 20 (0.9%) | 233 (9.9%) | 212 (9.0%) |
| 40–49 | 1678 | 61 (46–90) | 41 (2.4%) | 156 (9.3%) | 130 (7.7%) |
| 50–64 | 2601 | 65 (49–90) | 113 (4.3%) | 245 (9.4%) | 194 (7.5%) |
| 65+ | 2123 | 69 (50–95) | 123 (5.8%) | 302 (14.2%) | 226 (10.6%) |
| Gender | |||||
| Female | 6474 | 60 (45–86) | 153 (2.4%) | 657 (10.1%) | 547 (8.4%) |
| Male | 2281 | 70 (51–96) | 144 (6.3%) | 280 (12.3%) | 215 (9.4%) |
| BMI | |||||
| ≤ 30 | 4733 | 60 (45–88) | 158 (3.3%) | 492 (10.4%) | 406 (8.6%) |
| 31–35 | 2046 | 65 (50–90) | 71 (3.5%) | 211 (10.3%) | 170 (8.3%) |
| > 35 | 1573 | 68 (50–90) | 57 (3.6%) | 169 (10.7%) | 135 (8.6%) |
| Diagnosis | |||||
| CBD stone | 557 | 75 (55–118) | 52 (9.3%) | 84 (15.1%) | 67 (12.0%) |
| Cholecystitis | 2530 | 75 (56–104) | 165 (6.5%) | 332 (13.1%) | 262 (10.4%) |
| Colic | 4816 | 60 (45–77) | 62 (1.3%) | 406 (8.4%) | 331 (6.9%) |
| Pancreatitis | 846 | 69 (50–90) | 18 (2.1%) | 114 (13.5%) | 102 (12.1%) |
| Admission type | |||||
| Elective | 4117 | 60 (45–78) | 68 (1.7%) | 316 (7.7%) | 240 (5.8%) |
| Delay | 3247 | 65 (50–90) | 152 (4.7%) | 412 (12.7%) | 335 (10.3%) |
| Emergency | 1391 | 80 (60–110) | 77 (5.5%) | 209 (15.0%) | 187 (13.4%) |
| ASA | |||||
| 1 | 3354 | 60 (45–80) | 43 (1.3%) | 227 (8.3%) | 243 (7.2%) |
| 2 | 4436 | 65 (50–90) | 171 (3.9%) | 448 (11.0%) | 391 (8.8%) |
| 3 | 869 | 74 (53–101) | 77 (8.9%) | 153 (17.6%) | 118 (13.6%) |
| 4–5 | 22 | 82 (45–120) | 1 (4.5%) | 7 (31.8%) | 4 (18.2%) |
| USS | |||||
| No | 335 | 75 (58–110) | 24 (7.2%) | 57 (17.0%) | 41 (12.2%) |
| Yes | 8409 | 61 (46–90) | 273 (3.2%) | 878 (10.4%) | 720 (8.6%) |
| Thick-walled gallbladder | |||||
| No | 5748 | 60 (45–80) | 117 (2.0%) | 589 (10.2%) | 477 (8.3%) |
| Yes | 2800 | 72 (54–100) | 166 (5.9%) | 316 (11.3%) | 257 (9.2%) |
| CBD dilation | |||||
| No | 7201 | 60 (45–87) | 197 (2.7%) | 708 (9.8%) | 561 (7.8%) |
| Yes | 1351 | 72 (53–105) | 85 (6.3%) | 196 (14.5%) | 177 (13.1%) |
| CT | |||||
| No | 7397 | 60 (45–90) | 203 (2.7%) | 722 (9.8%) | 596 (8.1%) |
| Yes | 1257 | 72 (55–100) | 89 (7.1%) | 206 (16.4%) | 161 (12.8%) |
| MRCP | |||||
| No | 6398 | 60 (45–89) | 176 (2.8%) | 627 (9.8%) | 510 (8.0%) |
| Yes | 2264 | 70 (51–92) | 115 (5.1%) | 301 (13.3%) | 246 (10.9%) |
| ERCP | |||||
| No | 7719 | 61 (46–90) | 215 (2.8%) | 780 (10.1%) | 635 (8.2%) |
| Yes | 931 | 75 (55–105) | 76 (8.2%) | 147 (15.8%) | 121 (13.0%) |
Dichotomous outcomes are reported as N (%), with p values from Fisher’s exact test. Duration of surgery is reported as median (IQR), with p values from Mann–Whitney and Kruskal–Wallis tests for comparisons across two and more than two groups, respectively
Bold p values are significant at p < 0.05
Multivariable analyses of binary outcomes in the CholeS dataset
| Surgery > 90 min | Converted to open | 30-day complications | 30-day reintervention | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| Nassar grade | < | < | < | < | ||||
| 1 | 1 | – | 1 | – | 1 | – | 1 | – |
| 2 | 1.81 (1.52–2.15) | < | 2.07 (0.81–5.26) | 0.129 | 1.27 (1.05–1.55) |
| 1.10 (0.89–1.36) | 0.370 |
| 3 | 4.47 (3.76–5.31) | < | 12.26 (5.51–27.29) | < | 1.41 (1.13–1.75) |
| 1.22 (0.97–1.55) | 0.094 |
| 4–5 | 14.24 (11.44–17.74) | < | 115.6 (52.9–252.9) | < | 3.18 (2.48–4.08) | < | 2.91 (2.23–3.80) | < |
| Age (years) |
| 0.119 |
|
| ||||
| < 40 | 1 | – | 1 | – | 1 | – | 1 | – |
| 40–49 | 1.26 (1.04–1.53) |
| 1.67 (0.91–3.06) | 0.096 | 0.81 (0.64–1.02) | 0.070 | 0.77 (0.60–0.99) |
|
| 50–64 | 1.27 (1.06–1.51) |
| 1.94 (1.13–3.32) | 0.016 | 0.69 (0.55–0.86) | < | 0.62 (0.49–0.79) | < |
| 65+ | 1.23 (1.02–1.47) |
| 1.68 (0.97–2.92) | 0.067 | 0.94 (0.75–1.17) | 0.576 | 0.79 (0.62–1.01) | 0.064 |
| BMI | < |
|
|
| ||||
| ≤ 30 | 1 | – | – | – | – | – | – | – |
| 31–35 | 1.11 (0.95–1.28) | 0.182 | – | – | – | – | – | – |
| > 35 | 1.42 (1.21–1.66) | < | – | – | – | – | – | – |
| Diagnosis | < | < |
|
| ||||
| CBD stone | 1 | – | 1 | – | – | – | – | – |
| Cholecystitis | 0.69 (0.52–0.91) |
| 0.45 (0.30–0.68) | < | – | – | – | – |
| Colic | 0.55 (0.41–0.74) | < | 0.37 (0.23–0.59) | < | – | – | – | – |
| Pancreatitis | 0.74 (0.55–1.00) |
| 0.28 (0.14–0.55) | < | – | – | – | – |
| Admission type | < |
| < | < | ||||
| Elective | 1 | – | – | – | 1 | – | 1 | – |
| Delay | 1.18 (1.00–1.40) |
| – | – | 1.47 (1.22–1.75) | < | 1.48 (1.21–1.81) | < |
| Emergency | 1.88 (1.55–2.29) | < | – | – | 1.68 (1.35–2.09) | < | 2.02 (1.60–2.56) | < |
| ASA |
|
| < |
| ||||
| 1 | – | – | 1 | – | 1 | – | 1 | – |
| 2 | – | – | 1.68 (1.12–2.50) |
| 1.19 (0.99–1.42) | 0.061 | 1.16 (0.95–1.41) | 0.139 |
| 3 | – | – | 2.38 (1.48–3.82) | < | 1.66 (1.28–2.15) | < | 1.54 (1.16–2.05) |
|
| 4–5 | – | – | 0.67 (0.08–5.60) | 0.711 | 3.37 (1.28–8.85) |
| 1.83 (0.58–5.79) | 0.304 |
| CBD dilation | 1.55 (1.30–1.84) | < | – |
| 1.29 (1.07–1.55) |
| 1.46 (1.20–1.78) | < |
| CT | – |
| – |
| 1.28 (1.05–1.56) |
| 1.21 (0.97–1.50) | 0.084 |
| ERCP | 0.82 (0.65–1.04) | 0.098 | – |
| – |
| – |
|
| Thick-walled gallbladder | – |
| – |
| 0.69 (0.58–0.82) | < | 0.72 (0.60–0.87) | < |
Results are from multivariable binary logistic regression models, using a backwards stepwise variable selection approach, and with all factors in Supplementary Table 3 considered for inclusion
NS not selected for inclusion in the final model by the stepwise procedure
Bold p values are significant at p < 0.05
Available intra-operative difficulty scores for cholecystectomy
| Nassar scale (present paper) | |
|---|---|
| Grade 1 | |
| | |
| | |
| | |
| Grade 2 | |
| | |
| | |
| | |
| Grade 3 | |
| | |
| | |
| | |
| Grade 4 | |
| | |
| | |
| | |
| Correlation with outcome data available? | |
| Yes, this paper reports outcome from a single-surgeon series of 4089 patients and validation in a large multi-centre prospective cohort of 8820. Increasingly difficulty associated with worse clinical outcomes including 30-day complications, reintervention, length of stay and conversion to open surgery. Independent on multivariate analysis |